Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Feb 20.
Published in final edited form as: J Orthop Res. 2025 Sep 14;43(12):2125–2135. doi: 10.1002/jor.70060

Delayed Lubricin Injection Improves Cartilage Repair Tissue Quality in an In Vivo Rabbit Osteochondral Defect Model

Donghwan Yoon 1, Karan Vishwanath 2, John Dankert 3, James J Butler 3, Mohammad T Azam 3, Arianna L Gianakos 3, Marshall J Colville 4, Serafina G Lopez 5, Matthew J Paszek 6, Heidi L Reesink 4, John G Kennedy 3, Lawrence J Bonassar 1,5, Rebecca M Irwin 5,7
PMCID: PMC12917763  NIHMSID: NIHMS2141054  PMID: 40946210

Abstract

Osteochondral lesions (OCL) are common among young patients and often require surgical interventions since cartilage has a poor capacity for self-repair. Bone marrow stimulation (BMS) has been used clinically for decades to treat OCLs, however a persisting challenge with BMS and other cartilage repair strategies is the inferior quality of the resulting fibrocartilaginous repair tissue. Lubrication-based therapies have the potential to improve the quality of cartilage repair tissue as joint lubrication is linked to local cartilage tissue strains and subsequent cellular responses including death and apoptosis. Recently, a full length recombinant human lubricin (rhLubricin) was developed and has been shown to lower friction in cartilage. This study investigated the effect of a single delayed injection of rhLubricin on cartilage repair in an in vivo rabbit OCL model using gross macroscopic evaluation, surface profilometry, histology, and tribology. Moderate improvement in macroscopic scores for cartilage repair were observed. Notably, quantitative analysis of Safranin-O histology showed that rhLubricin treated joints had significantly higher glycosaminoglycan content compared to saline treated joints, and there were no differences in repair integration between groups. Furthermore, rhLubricin treated joints had significantly lower friction coefficients tested across three sliding speeds compared to saline treated joints (rhLubricin: 0.15 ± 0.03 at 0.1 mm/s to 0.12 ± 0.03 at 10 mm/s, Saline: 0.22 ± 0.06 at 0.1 mm/s to 0.19 ± 0.05 at 10 mm/s). Overall, a single delayed injection of rhLubricin improved the quality and lubricating ability of the repair cartilage tissue without inhibiting repair tissue integration.

Keywords: friction, histology, lubrication, tribosupplement, tribosupplementation

1 ∣. Introduction

Osteochondral lesions (OCLs) are typically the result of a traumatic injury to cartilage and/or the underlying bone in joints. They are common in the knee and ankle joint and may be associated with chondral degeneration and the development of osteoarthritis [1]. As cartilage has a poor capacity for self-repair, surgical intervention is often needed [2, 3]. Bone marrow stimulation (BMS) is a repair method that involves creating a bleeding bed by violating the subchondral plate thereby releasing mesenchymal stem cells and promoting hyaline-like tissue repair [4]. However, BMS produces fibrocartilage that is mechanically inferior compared to native cartilage tissue and therefore leaves the joint susceptible to mechanically induced damage [5-9]. OCLs are prevalent in young adult patients, highlighting the clinical need for surgical interventions that restore the mechanical function of cartilage tissue while preserving joint health [10, 11].

Microscale assessment of the mechanical strains and stresses as well as tribological properties of healthy and diseased tissue in several species have been well documented in cartilage explants [12-18]. Microscale tissue strains are strongly correlated with cellular outcomes, where higher strains correspond to increased cell death, apoptosis, and mitochondrial dysfunction in cartilage [14, 19-22]. Numerous studies have shown that alterations in lubrication change cartilage tissue strains, and subsequently will affect cell responses [18, 23-25]. Synovial fluid (SF) achieves highly efficient lubrication through the combination of two macromolecules: hyaluronic acid and lubricin [26-29]. To create a lower stress environment in articulating joints, viscosupplementation, or supplementation with a highly viscous material like hyaluronic acid, has been the cornerstone of OA treatment for decades with variable success [30, 31]. Recently, a bioengineering approach using codon optimization was used to produce a recombinant lubricin with the native human N- and C-terminal domains and a lubricin-inspired mucin domain containing 59 KEPAPTTP-rich repeats (rhLubricin) [32-34]. Lubricin's role in cartilage lubrication has been well documented with several studies reporting increased friction with lubricin degradation and decreased friction with lubricin supplementation across various tribometer systems [25, 29, 33, 35]. Lubricin has also been purported to have an anti-inflammatory role and could possibly lower the interfacial strains in the joint [20, 36]. However, little is known about its ability to alter the quality of repaired cartilage.

Previously, it has been shown that lubricin incubation performed immediately after OCL defect creation inhibited integration between repair and native cartilage due to its anti-adhesive properties in vitro, and similar interference with tissue repair has been reported in vivo in tendon models [37-39]. However, lubricin is critical for proper joint lubrication, maintaining low friction in the joint and preserving cell viability [20]. Therefore, we hypothesized that by delaying the administration of lubricin into the joint following OCL repair such that repair tissue has already filled in the defect site, lubricin will improve the quality of the repair tissue without impeding the integration of the repair and adjacent native tissue. To investigate this hypothesis, this study evaluated whether a single delayed injection of rhLubricin can improve cartilage repair in a New Zealand rabbit OCL model. We hypothesize that rhLubricin injections will: (A) improve the quality of the repair tissue, (B) improve the mechanics of the repair tissue, and (C) not impede the integration of the repair and native cartilage tissue.

2 ∣. Materials and Methods

2.1 ∣. In Vivo Study Design

The NYU Institutional Animal Care and Use Committee approved all surgical procedures and experimental designs (IACUC 2017-0025). Bilateral 3 mm diameter osteochondral (OCL) defects along with BMS were performed on the medial femoral condyle of 18 female New Zealand rabbits (12-weeks old) as previously described [6]. Further details can be found in the Supplemental Materials. The medial joint compartment was chosen as it bears substantial compressive loads during animal gait (~39% of body weight) [40]. By using only female rabbits, biological variability was reduced, focusing on whether delayed lubricin injection has an effect without the additional confounder of sex-based biological differences. Furthermore, females are less prone to aggressive behavior than males therefore lowering inter-animal aggression for better postoperative outcomes. A recombinant full-length human lubricin was produced and purified as previous described with a reported joint residence half-life of 45 days in rats [33, 41]. This rhLubricin was created using codon scrambling and human embryonic kidney cells (HEK293) to produce a recombinant lubricin with the native human N- and C-terminal domains and a lubricin-inspired mucin domain containing 59 KEPAPTTP-rich repeats [33]. A saline vehicle control was formulated as 20 mM Na2HPO4, 100 mM NaCl, pH 7.2 to match the rhLubricin solution (Sigma-Aldrich, St. Louis, MO). Both rhLubricin and the vehicle were terminally sterilized by 0.22 μm filtration (Pall Corporation, New York, NY), aliquoted into septum-top serum vials, frozen in liquid nitrogen and stored at −80°C until use. The timepoint of rhLubricin and saline injections were performed 4 weeks after surgery, thereby providing sufficient time for repair tissue infill to have been achieved [6]. Injection volumes were 100 μl for saline and rhLubricin. Joints were randomized for treatment and injections were performed in an unblinded manner. The rhLubricin concentration was set at 1 mg/ml, which has been shown to reduce friction by half relevant to a saline control and demonstrates friction values consistent with synovial fluid in cartilage tribology experiments [25, 33]. Further, the friction metrics reported for the rhLubricin used in the present study is consistent with other forms of recombinant lubricin products [42]. Control limbs received no defect and no injection. Confounders such as the order of treatments and measurements were not controlled for in this study. Animals were euthanized at 12 weeks postoperatively, limbs were stored on ice, and the femoral condyles were collected within 12 h (Figure 1). A total of 18 rabbits (36 joints) were randomly separated into three groups: rhLubricin n = 12 joints; saline n = 16 joints; control n = 8 joints. One saline joint was excluded from the analysis due to an exposed joint capsule. Joints were labeled in 50 ml falcon tubes (VWR International, Radnor, PA) with sample numbers (blinded by D.Y. and K.V.) macroscopically assessed, analyzed using profilometry and subsequently randomly divided for friction testing or histological analyzes.

FIGURE 1 ∣.

FIGURE 1 ∣

Flowchart of study design and methods used to investigate the outcome measures of gross scoring, surface roughness, coefficient of friction, histology, and lubricin immunohistochemistry of the study.

2.2 ∣. Macroscopic Evaluation of Repair Tissue

To assess the quality of the repair, macroscopic evaluation was performed. Modified International cartilage regeneration repair assessment (ICRS) scores [43, 44] and Goebel scores [45] were collected from 4 to 5 blinded observers for the saline and rhLubricin groups (n = 6) on the OCL repair site of the joint. Observers were given a visual training set to become accustomed to the scoring criteria (Supporting information Table S1 and Table 2). The two methods were both evaluated and median scores from the 4 to 5 observers were compared between saline treated and rhLubricin treated groups.

2.3 ∣. Surface Profilometry

To assess the roughness and surface characteristics of the repair tissue, the root mean square surface roughness (Rq) was measured in the central region of the defect site on the medial femoral condyle (rhLubricin n = 10, Saline n = 15, Ctrl n = 6) using a Keyence VK-X260 confocal laser-scanning profilometer [46, 47]. Roughness measurements were taken with a 10× lens that has a working distance of 16.5 mm and capture size of 1412 mm × 1060 mm. For each sample, the surface of the central region of the defect site was scanned under hydrated conditions to preserve native morphology. From each scan, two orthogonal 2D z-height (A) profiles, one vertical and one horizontal, were extracted from the center of the scanned area. These profiles were smoothed by fitting the cartilage surface scan to a 5-parameter waveform to account for gross curvature and waviness. The RMS roughness was then computed for each profile using the following equation (i.e., the standard deviation of residual z-height fluctuations from the smoothed contour) and averaged across the two z-height profiles to obtain a single RMS roughness value per defect site.

Rq=[(1L)0LZ(x)2dx]12.

L = evaluation length, Z(x) = the profile height function.

The laser-scanning profilometer scans a convergent laser beam over the surface of the tissue. No physical interaction was present, therefore allowing the surface of the tissue to remain intact and hydrated to minimize the effect of surface degradation or dehydration for further analyzes. The data was smoothed by fitting the contour of the cartilage surface to a 5-parameter waveform. Root mean square (RMS) roughness was measured in the center of the defect with a vertical and horizontal measurement. The average RMS roughness was calculated and reported as the roughness of the central region of the defect site.

2.4 ∣. Sample Preparation

Following macroscopic scoring and profilometry, full thickness 6 mm diameter cylindrical osteochondral explants were obtained from defect site of the medial femoral condyles of the rabbits. The cylindrical explants of the control, saline, and rhLubricin treated groups were divided into two groups: (1) friction testing or (2) histological staining. Samples designated for histological staining were bisected into hemicylinders in the posteroanterior direction. The bisected hemicylinders were frozen immediately after collection and were stored without any buffer to prevent crystallization forming on the cartilage.

2.5 ∣. Histology, GAG Quantification, and Histopathology Scoring

Histological staining of the samples (n = 3 per group) was performed by the Clinical Pathology Core (Cornell College of Veterinary Medicine, Ithaca, NY). The bisected hemicylinder explants were fixed in 10 vol/vol% neutral buffer formalin for 24–48 h, rinsed with 70% ethanol, decalcified in a solution made from equal parts of 20% Sodium Citrate and 44% Formic Acid, sectioned in 4 μm thickness slices, and stained with Safranin-O and Picrosirius red to observe relative proteoglycan content and collagen content, respectively. The sections were imaged using a Keyence BZ-X810 microscope at 10× magnification. Proteoglycan to defect area ratio was quantified using ImageJ (NIH, Bethesda, MD) by measuring the area of the 3 mm wide defect and manually quantifying the area of proteoglycan content within the 3 mm wide defect area (Safranin O area/Cartilage area * 100) [48]. The manual area coverage quantification was repeated five times and averaged to reduce variation within measurements. To assess the histopathological grading of the repair tissue, consensus scoring was performed by three observers (E.Y., K.V., R.M.I.) using a modified version of a previously established semi-quantitative scoring system was used (Supporting information Table S3) [49]. Observers were blinded to treatment for scoring.

2.6 ∣. Immunohistochemistry

Lubricin immunohistochemistry was performed on osteochondral sections from the rabbit condyles to further investigate lubricin content and distribution in these samples as previously described [50]. Samples were fixed, decalcified, paraffin embedded, and sectioned as described above (Histology, GAG quantification, and histopathology scoring section). Immunohistochemistry was conducted using a modified Vectastain ABC kit protocol (Vector Laboratories, Burlingame, CA) and an anti-lubricin monoclonal antibody 9G3 at a 1:250 dilution (MABT401, Sigma Aldrich, St. Louis, MO) [50, 51]. Controls were run in parallel with samples and control and experimental samples were stained in the same batch processes and exposed to the same duration and concentration of reagents. All slides were counterstained with hematoxylin. Images were obtained with a Keyence BZ-X810 microscope at 10x magnification. Images were stitched with ImageJ (NIH, Bethesda, MD) [48].

2.7 ∣. Tribological Evaluation of the Osteochondral Cores

Tribological characterization of the osteochondral cores (rhLubricin n = 4, Saline n = 6, Ctrl n = 6) was performed using a previously described, custom cartilage-on-glass tribometer [24, 25]. Frozen osteochondral cores from all treatment groups were thawed in PBS with protease inhibitors (50 ml buffer per tablet, Cat. No. A32965, Thermo Fisher Scientific, Waltham, MA) before the friction tests. The samples were glued to brass posts (6 mm diameter), mated against a polished glass surface and tested immersed to prevent drying in healthy bovine synovial fluid (BSF, Lampire Biologics, Pipersville, PA). The cores were then compressed to a normal force of 5.5 ± 1.5 N and allowed to stress relax for 1 h, a duration long enough to ensure complete relaxation of cartilage under compression [52-55]. After equilibration, the glass counter-face was reciprocated at sliding speeds of 0.1, 1, and 10 mm/s using a DC motor. These compression levels and sliding speeds were chosen based on the strong correlation of the reported friction data to clinical outcomes and biochemical markers of inflammation [56]. Furthermore, lubricin is a critical boundary lubricant, and this range of sliding speeds allow for the investigation of whether a rhLubricin injection affects friction in the different lubrication regimes of cartilage. The coefficient of friction (μ) was recorded as the ratio of shear to normal force measured by a biaxial load cell. All friction coefficients were calculated at the end of sliding when friction reached an equilibrium value and then averaged in the forward and reverse sliding directions to give a mean value for the coefficient of friction at each speed [57].

2.8 ∣. Statistical Analyzes

2.8.1 ∣. Macroscopic and Histological Scoring for Cartilage Repair

Differences in the macroscopic scoring for cartilage repair between the rhLubricin and saline treated samples and statistical significance for histological scoring and the GAG/defect area ratio was determined using Tukey's honestly significant difference (HSD) test in R Studio (Posit Software, Boston, MA). Significance was evaluated at p < 0.05.

2.8.2 ∣. Surface Roughness Data

Differences in the RMS roughness between the lubricin and saline treated samples were evaluated using Welch's two-sample t-test using the t-test function in R Studio (Posit Software, Boston, MA). Significance was evaluated at p < 0.05.

2.8.3 ∣. Tribology Data

A linear mixed effects regression model was used to fit coefficient of friction as a function of the treatment at each speed. Random effects in the model included the limb nested within each rabbit. Post-hoc pairwise comparisons (adjusted for multiple groups) were conducted to estimate the difference in the estimated marginal means of the coefficient of friction between the rhLubricin, saline, and control groups within each sliding speed using the emmeans package in R Studio. Statistical significance was evaluated at p < 0.05. A repeated measures Pearson correlation analysis was conducted in R Studio using the rmcorr and lme4 packages to assess the difference between the coefficient of friction of the cores for the three groups, with the articulation speeds used as the repeated measure in the analysis.

3 ∣. Results

3.1 ∣. Gross Repair Tissue Characterization

Gross images of the OCL defects demonstrated repair tissue infill following rhLubricin or saline injections (Figure 2A). Visual examination showed the repair tissue was more fibrillated and rougher compared to the surrounding native tissue for both treatments. For further quantitative analysis, gross macroscopic scoring of the repair tissue using a modified ICRS score and a Goebel score was performed (Figure 2B,C). The scores for healthy control condyles were 16 and 20 for the modified ICRS score and Goebel score, respectively. The median values for saline and rhLubricin for the modified ICRS score were 7.8 and 10.3, respectively. The median values for saline and rhLubricin for the Goebel score were 10.5 and 13.5, respectively. Both scoring methods showed a trend for improved repair with rhLubricin compared to saline but were not statistically significant (ICRS: p = 0.08, Goebel: p = 0.11). Notably, there were no differences between saline and rhLubricin treated joints in the subscores that corresponded to repair tissue integration (Figure 2C,E, p > 0.90). The remaining subscores for each scoring system are presented in Supporting information Tables 4 and 5.

FIGURE 2 ∣.

FIGURE 2 ∣

(A) Representative gross image of the medial condyle for control, saline and rhLubricin groups. Total scores for the (B) modified ICRS and (D) Goebel score are shown. Subscores pertaining to repair tissue integration are shown for both the ICRS (C) and Goebel (E) scores. Asterisks indicate statistical significance (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

3.2 ∣. Histological Assessment of Tissue Repair Quality and Integration

Histological staining revealed spatial distributions of proteoglycans, lubricin, and fibrillar collagen in the control and repair tissue samples. Both defect groups showed decreased proteoglycan content in the repair tissue compared to adjacent healthy cartilage and to the uninjured control (Figure 3A-C). Within the defect groups, joints treated with rhLubricin had increased proteoglycan staining in the deeper region of repair tissue compared to saline treated joints (Figure 3B,C). In the uninjured control and the cartilage tissue adjacent to the defect for both saline and rhLubricin treated joints, lubricin staining was concentrated at the surface of the cartilage tissue (Figure 3D[i],E[ii],F[iv]). rhLubricin treated joints had enriched lubricin staining at the tissue surface compared to saline treated joints in the cartilage tissue adjacent to the defect (Figure 3E[ii],F[iv]). For the repair cartilage tissue, saline treated tissue had lubricin staining throughout with no apparent differences through the repair tissue depth (Figure 3[iii]). In contrast, the rhLubricin repair tissue had enriched lubricin staining at the surface of the tissue that diminished in the deeper regions (Figure 3[v]). Notably, there was no enrichment of lubricin staining at the interface of repair for either saline or rhLubricin treated groups. Additionally, there were no obvious differences in collagen organization observed under brightfield and polarized light between saline and rhLubricin groups (Figure 3J-L).

FIGURE 3 ∣.

FIGURE 3 ∣

Histological stains of Safranin-O (A–C), lubricin immunohistochemistry (D–F), and Picrosirius red observed under brightfield (BF, G–I) and polarized light (J–L). Dashed red lines in panels B and C indicate the location of the defect. Scale bar = 500 μm for all images.

An enrichment of GAG content in the rhLubricin treated group relative to the saline treated group was observed by histological staining with Safranin-O. This observation was quantified using a GAG to defect area (3 mm) ratio with mean values of 63%, 32%, and 12% for control, rhLubricin, and saline respectively (Figure 4A). The rhLubricin treated group did not restore the GAG content to native levels (p < 0.05). However, the GAG/Defect area ratio demonstrated that rhLubricin treated group had a significant improvement in GAG content compared to the saline treated group (p < 0.05). Histological assessment performed using a previously established scoring system (Supporting information Table S1) [49] showed differences between healthy and defect tissue (Figure 4B-J). Combined histopathological scoring indicated there was a clear difference between healthy controls and the rhLubricin and saline treated defect groups (Figure 4B). Individual sub-scores of cell distribution, Safranin-O stain, and tidemark reformation depicted improvements in the quality of repair for the rhLubricin treated group compared to the saline treated group (Figure 4C,I,J). Notably, there was no difference in tissue integration scoring between saline and rhLubricin treated groups (Figure 4E). Safranin-O stained sections used for histological scoring can be found in Supporting information Figure 1.

FIGURE 4 ∣.

FIGURE 4 ∣

(A) Quantification of the Safranin-O stains to defect area. (B) Total scores and (C–J) sub-scores from semi-quantitative histological scoring system. Asterisks indicate statistical significance (*p < 0.05, **p < 0.01, ***p < 0.001).

3.3 ∣. Surface Roughness and Tribological Evaluation

Surface profilometry revealed differences between the roughness of the center region of the control and repair tissue for both rhLubricin and saline treated groups. The mean value for the RMS roughness in the center of the defect site for the healthy control condyles was 4.0 ± 1.3 μm. The rhLubricin treated group had lower surface roughness measurements compared to the saline treated group, but this was not statistically significant (p = 0.16; rhLubricin: 8.1 ± 2.7 μm; saline: 11.5 ± 7.2 μm). Surface roughness measurements for rhLubricin and saline treated samples were both significantly higher than the healthy control (p < 0.05) (Figure 5A).

FIGURE 5 ∣.

FIGURE 5 ∣

(A) Surface roughness measurements and (B) coefficient of friction of the center of the defect across three sliding speeds. Treatment comparisons within sliding speeds are from a post-hoc analysis from a linear mixed effects model. Treatment level statistical significance reported adjacent to the treatment labels in panel B are from a repeated measures linear mixed effect model where sliding speed was a repeated measure. Asterisks indicate statistical significance (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

Tribological evaluation revealed distinct differences in friction coefficient of osteochondral cores between the control (no defect), rhLubricin and saline treated groups when lubricated in healthy bovine SF. Control samples exhibited low coefficients of friction ranging from μavg = 0.08 ± 0.01 at 0.1 mm/s to 0.065 ± 0.02 at 10 mm/s. The rhLubricin treated samples had moderate friction coefficients ranging from 0.15 ± 0.03 at 0.1 mm/s to 0.12 ± 0.03 at 10 mm/s, and the saline treated groups had the highest friction coefficients, ranging from 0.22 ± 0.06 at 0.1 mm/s to 0.19 ± 0.05 at 10 mm/s. The control samples had friction coefficients that were significantly lower than the saline treated samples (Figure 5, p < 0.05 from 0.1 to 10 mm/s), but were not statistically different from rhLubricin treated samples (p = 0.27, 0.38, 0.49 from 0.1 to 10 mm/s). Additionally, there were no statistically significant differences in the friction coefficient between the rhLubricin and saline treated groups at any given sliding speed (Figure 5B, p > 0.05). However, when comparing the friction coefficient of the overall treatments using sliding speed as repeated measures, rhLubricin treated joints were significantly lower than saline treated controls (Figure 5B, p < 0.01).

4 ∣. Discussion

The objective of this study was to investigate whether a single delayed injection of lubricin after surgery would promote cartilage regeneration in an in vivo preclinical rabbit model. Our results show that the delayed injection of rhLubricin after allowing initial repair tissue infill improved the overall quality of the repair cartilage tissue. Increased GAG deposition, improved macroscopic histopathological characteristics, and friction coefficients not different from healthy controls were observed in rhLubricin treated repair tissue. Sub-scores for histopathology showed improvements in cell distribution, proteoglycan staining, and tidemark reformation and there was no difference in repair cartilage tissue integration. These results suggest that delayed lubricin injections after OCL repair surgery could provide a therapeutic benefit for overall cartilage repair tissue quality without compromising repair tissue integration.

Lubricin is a mucinous glycoprotein that acts as a boundary lubricant in articulating joints and is critical for joint health [20]. In mice with a homozygous lubricin knockout (Prg4−/−), the whole joint coefficient of friction is increased along with elevated levels of chondrocyte apoptosis, highlighting the importance of lubricin in cartilage lubrication [20]. Similar observations of apoptosis associated with the loss of articular surface lubricin have also been reported in Prg4 gene trap mice [58]. A concern for the application of lubricin for repair of cartilage focal defects is the integration of the repair tissue as lubricin coating the surface of both cartilage and meniscus tissues has been shown to inhibit integrative repair [37, 59, 60]. Specifically for cartilage, it has been shown that exogenous lubricin supplementation in culture inhibits cartilage repair in vitro [37]. To prevent the coating of the repair tissue interface with exogenous lubricin, rhLubricin was delayed by 4 weeks after creating an osteochondral defect with BMS. Previous studies have shown with this osteochondral defect model that 4 weeks is sufficient for repair tissue infill into the defect site [6, 61]. Gross evaluation of the repair tissue using the established modified ICRS score and Goebel scoring systems showed that the rhLubricin treated group did not impede the repair tissue integration. Histologically, there was no difference in integration from ICRS scoring and there was no enrichment of lubricin at the repair interface. Thus, lubricin supplementation did not impede or inhibit the integration of repair tissue for OCL defects in this study.

While BMS has historically been widely used for cartilage repair, one of the prevailing challenges is the infill of fibrocartilage repair tissue that lacks the structure, composition, and mechanical properties of native hyaline cartilage [4, 62, 63]. For small chondral defects, microfracture remains a common first line treatment, but for larger defects or failed BMS, more advanced approaches such as autologous chondrocyte implantation (ACI), matrix-induced ACI, or emerging scaffold-based techniques (e.g., Agili-C) are increasingly favored due to their potential to regenerate more hyaline-like tissue [62-66]. In this study, augmenting BMS with a delayed lubricin injection resulted in superior repair tissue quality. Increased GAG content was qualitatively observed and quantified in the cartilage repair tissue of rhLubricin treated groups compared to the saline treated group. This coincides with previous studies that saw increased GAG content with viscosupplementation [67]. As GAGs are critical for the compressive properties of cartilage tissue, this elevated GAG content could likely influence the compressive properties of cartilage as shown in previous studies thus leaving the repair cartilage tissue less prone to mechanically induced damage [68].

Further histological analysis with a modified version of a previously established semi-quantitative scoring system revealed interesting features between healthy controls, saline-treated defects, and rhLubricin-treated defects. Although combined histological scores within the defect group which were injected with either saline or rhLubricin did not show any significant differences, meaningful differences were noted within individual features that were analyzed. Apart from the improvement of restoration of GAG content, improvement in cell distribution as well as tidemark reformation were observed within the individual subscores for the rhLubricin group compared to saline treated. Proper cell distribution is critical to produce extracellular matrix resembling native tissue, therefore decreasing the probability of compromised mechanical integrity [69, 70]. Improved tidemark reformation in the rhLubricin treated groups also suggests improvement in the long-term stability of the boundary between calcified and non-calcified cartilage which maintains the structure and function of the repair tissue. Incomplete or delayed tidemark reformation also suggests inferior quality of repair which may be prone to degeneration [71].

Histological grading of surface fibrillation found no significant differences between control, saline, or rhLubricin groups. In contrast, profilometry analyzes characterized a significant increase in both defect groups (saline and rhLubricin) compared to control. This disparity could result from the inherent differences in the two measurements; it is possible to have roughening of the surface without fibrillation. Further, tissue surface roughness from profilometry provides a quantitative, holistic analysis of the tissue over a ~1.4 mm2 area whereas histological grading provides a qualitative analysis on a single 2D section of the repair tissue. The difference in surface roughness measured from profilometry revealed decreased surface roughness for the rhLubricin treated group compared to the saline treated group and was trending towards statistical significance (p = 0.16). Control group samples exhibited surface roughness values similar to those previously noted in literature [72]. Although not statistically different, rhLubricin treated samples were observed to have a mean value of 4 μm of difference in surface roughness compared to saline treated tissue, which corresponds to the total roughness of a healthy condyle. Notably, the coefficient of friction was significantly different between saline and rhLubricin treated groups where the rhLubricin treated joints had significantly lower friction. In OA models, it has been shown that the lubricating properties have a strong correlation to clinical data where lower coefficient of frictions correlated with lower pain scores [56]. Although the native curvature of the joint surface is lost upon core extraction, all osteochondral cores used were carefully extracted and then manually trimmed to achieve a flat, cylindrical shape to the best extent possible. This preparation was done to standardize the articulating surface and minimize variability in contact area during testing. Furthermore, a consistent and relatively high normal force was applied before initiating tribological articulation, which contributed to establishing reliable and comparable contact conditions across all groups. The rhLubricin in the present study lowered friction in repair cartilage tissue, consistent with its ability to lower friction in healthy cartilage explants, and therefore may have implications for affecting patient pain that could be evaluated in future studies [41].

The influence of lubricin on cartilage health has been studied across multiple animal models. The majority of these studies have been performed in OA models, and several reports have linked lubricin depletion in the knee joint with OA development [20, 37, 73-76]. In addition, a recent review found that lubricin supplementation across multiple OA models has shown beneficial effects based on histological, morphological, functional, and gene expression outcome measures [73]. Importantly, this review also noted that lubricin concentrations following joint injury or in OA vary widely depending on injury model, time point, and species. Specifically in rabbits, synovial fluid lubricin concentrations have been shown decrease following ACL injury [77, 78]. In light of this, our rationale for exogenous rhLubricin administration is based on the premise that in this rabbit model, endogenous lubricin levels are likely reduced following injury, and rhLubricin supplementation could help restore boundary lubrication. While hyaluronic acid and hydrostatic pressurization also play critical roles in joint lubrication, our study was designed to isolate and examine the effects of rhLubricin supplementation alone [79, 80].

Given the scarcity of studies examining lubricin supplementation in cartilage defect models, this study addresses an important gap in the literature. Previous studies have evaluated rhLubricin injections at various doses across multiple animal models, complicating direct comparison of results between studies. For example, in a minipig study following destabilization of the medial meniscus, total rhPRG4 used was ~0.25 mg/kg over 3 injections [34]. In the present study, a single dose of 0.02 mg/kg was administered (assuming 5 kg for an adult New Zealand white rabbit). While the dose used here is roughly an order of magnitude lower compared to the minipig study, our findings still suggest measurable biological effects, indicating that even a lower recombinant lubricin dose may exert therapeutic activity in this context. Furthermore, this study selected the rhLubricin dose that correlates to coefficients of friction within the same order of magnitude (μ ≅ 0.1) as previously reported for other variants of lubricin [25, 33, 42, 74].

There exist several limitations in this study that must be addressed while interpreting these results. First, this study investigated a single injection at a single time point. Future work could address multiple injections at different time points to answer whether increased rhLubricin injections or earlier/later injection time points improves or dampens the outcomes identified from this study. Second, the sample size for this study was determined using a power analysis based on the primary outcome variable, the histological score. This sample size was sufficient to detect statistical differences in the histological and functional lubricating properties of the three groups (control, rhLubricin treated, and saline treated). However, it is likely underpowered to detect smaller effect sizes in secondary outcomes, including gross scoring, surface roughness, and friction coefficients, particularly when comparing rhLubricin to saline or control groups. With an increased sample size, further differences between control tissue, saline treated, and rhLubricin treated repair tissues would likely be observed for gross scoring (ICRS and Goebel) and friction measurements. Future studies should include a larger sample size to properly characterize these differences. Furthermore, this study evaluated a single dose of rhLubricin (100 μl of 1 mg/ml) based off in vitro friction measurements, but other dose concentrations could be explored [41, 56]. While important, these complexities were outside of the scope of this study.

Overall, these data identified improvements in overall quality of repair tissue as well as functional improvements in the lubricating ability of the rhLubricin treated repair cartilage compared to saline treated defects. Additionally, rhLubricin treated joints had enriched lubricin staining at the tissue surface compared to saline treated joints in the cartilage tissue adjacent to the defect. Importantly, there was no difference in repair tissue integration between the saline treated and rhLubricin treated groups. Together, these results identify that a single delayed injection of rhLubricin in an in vivo rabbit model does not inhibit cartilage repair and improves the quality of the repair tissue.

Supplementary Material

Supplemental Files

Additional supporting information can be found online in the Supporting Information section.

Figure S1. Safranin-O sections for all samples used in histological assessments (n = 3/group). Scale bars = 1 mm. Figure S2. Cell distribution scoring examples for Safranin-O sections. Table S1. Scoring criteria for the modified ICRS score. Table S2. Scoring criteria for Goebel score. Table S3. Histopathological scoring criteria. Table S4. Subscores for modified ICRS gross scoring system. Means ± SD are reported. Table S5. Subscores for Goebel gross scoring system. Mean ± SD are reported.

Acknowledgments

This study was partially funded by the Arthroscopic Association of North America (J.G.K. and R.M.I.), the Cornell Ignite Fellow for New Venture (M.J.C.), the Cornell Technology Acceleration and Maturation Fund (H.L.R. and M.J.P.), the Cornell Technology Acceleration and Maturation Fund (M.J.C.), the NSF LEAP-HI CMMI 2245367 (L.J.B., H.L.R., and M.J.P.), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number T32AR078751 (S.G.L.). This study made use of the Cornell Center for Materials Research shared instrumentation facility. The authors would like to acknowledge Caroline Thompson, Ruben Trujillo, Salman Matan, and Megh Prajapti for their assistance with gross scoring of the condyles.

Funding:

This study was partially funded by the Arthroscopic Association of North America (J.G.K. and R.M.I.), the Cornell Ignite Fellow for New Venture (M.J.C.), the Cornell Technology Acceleration and Maturation Fund (H.L.R. and M.J.P.), the Cornell Technology Acceleration and Maturation Fund (M.J.C.), the NSF LEAP-HI CMMI 2245367 (L.J.B., H.L.R., and M.J.P.), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number T32AR078751 (S.G.L.).

Footnotes

Conflicts of Interest

Dr. Bonassar is a cofounder of and hold equity in 3DBio Corp. Dr. Colville, Dr. Reesink and Dr. Paszek are named inventors in pending patents related to the design and manufacturing of rhLubricin, assigned to Cornell University.

References

  • 1.Chau MM, Klimstra MA, Wise KL, et al. , “Osteochondritis Dissecans,” Journal of Bone and Joint Surgery 103, no. 12 (2021): 1132–1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chiang H and Jiang C-C, “Repair of Articular Cartilage Defects: Review and Perspectives,” Journal of the Formosan Medical Association 108, no. 2 (2009): 87–101. [DOI] [PubMed] [Google Scholar]
  • 3.Cong B, Sun T, Zhao Y, and Chen M, “Current and Novel Therapeutics for Articular Cartilage Repair and Regeneration,” Therapeutics and Clinical Risk Management 19 (2023): 485–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Redondo M, Beer A, and Yanke A, “Cartilage Restoration: Microfracture and Osteochondral Autograft Transplantation,” Journal of Knee Surgery 31, no. 3 (2018): 231–238. [DOI] [PubMed] [Google Scholar]
  • 5.Bilsel K, Yildiz F, Kapicioglu M, et al. , “Efficacy of Bone Marrow-Stimulating Technique in Rotator Cuff Repair,” Journal of Shoulder and Elbow Surgery 26, no. 8 (2017): 1360–1366. [DOI] [PubMed] [Google Scholar]
  • 6.Yasui Y, Dankert JF, Tonogai I, et al. , “The Effect of Single vs Serial Platelet-Rich Plasma Injections in Osteochondral Lesions Treated With Microfracture: An In Vivo Rabbit Model,” American Journal of Sports Medicine 49, no. 14 (2021): 3876–3886. [DOI] [PubMed] [Google Scholar]
  • 7.Hannon CP, Ross KA, Murawski CD, et al. , “Arthroscopic Bone Marrow Stimulation and Concentrated Bone Marrow Aspirate for Osteochondral Lesions of the Talus: A Case-Control Study of Functional and Magnetic Resonance Observation of Cartilage Repair Tissue Outcomes,” Arthroscopy: The Journal of Arthroscopic and Related Surgery 32, no. 2 (2016): 339–347. [DOI] [PubMed] [Google Scholar]
  • 8.Seow D, Yasui Y, Hutchinson ID, Hurley ET, Shimozono Y, and Kennedy JG, “The Subchondral Bone Is Affected by Bone Marrow Stimulation: A Systematic Review of Preclinical Animal Studies,” Cartilage 10, no. 1 (2019): 70–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shapiro F, Koide S, and Glimcher MJ, “Cell Origin and Differentiation in the Repair of Full-Thickness Defects of Articular Cartilage,” Journal of Bone and Joint Surgery 75, no. 4 (1993): 532–553. [DOI] [PubMed] [Google Scholar]
  • 10.Hinckel B, Pratte E, Baumann C, et al. , Patellofemoral Cartilage Restoration: A Systematic Review and Meta-Analysis of Clinical Outcomes, (2020), https://journals.sagepub.com/doi/10.1177/0363546519886853?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed. [DOI] [PubMed] [Google Scholar]
  • 11.Orth P, Gao L, and Madry H, “Microfracture for Cartilage Repair in the Knee: A Systematic Review of the Contemporary Literature,” Knee Surgery, Sports Traumatology, Arthroscopy 28, no. 3 (2020): 670–706. [DOI] [PubMed] [Google Scholar]
  • 12.Buckley MR, Bergou AJ, Fouchard J, Bonassar LJ, and Cohen I, “High-Resolution Spatial Mapping of Shear Properties in Cartilage,” Journal of Biomechanics 43, no. 4 (2010): 796–800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Silverberg JL, Barrett AR, Das M, Petersen PB, Bonassar LJ, and Cohen I, “Structure-Function Relations and Rigidity Percolation in the Shear Properties of Articular Cartilage,” Biophysical Journal 107, no. 7 (2014): 1721–1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Irwin RM, Feeney E, Secchieri C, et al. , “Distinct Tribological Endotypes of Pathological Human Synovial Fluid Reveal Characteristic Biomarkers and Variation in Efficacy of Viscosupplementation at Reducing Local Strains in Articular Cartilage,” Osteoarthritis and Cartilage 28, no. 4 (2020): 492–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vishwanath K, McClure SR, and Bonassar LJ, “Polyacrylamide Hydrogel Lubricates Cartilage After Biochemical Degradation and Mechanical Injury,” Journal of Orthopaedic Research 41, no. 1 (2023): 63–71. [DOI] [PubMed] [Google Scholar]
  • 16.Yoon D, Peralta S, Fiani N, et al. , “Relationship Between Microscale Shear Modulus, Composition, and Structure in Porcine, Canine, and Human Temporomandibular-Joint Cartilage: Relevance to Disease and Degeneration,” European Cells and Materials 46 (2023): 40–56. [Google Scholar]
  • 17.Wyse Jackson T, Michel J, Lwin P, et al. , “Structural Origins of Cartilage Shear Mechanics,” Science Advances 8, no. 6 (2022): eabk2805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wong BL, Bae WC, Chun J, Gratz KR, Lotz M, and Sah RL, “Biomechanics of Cartilage Articulation: Effects of Lubrication and Degeneration on Shear Deformation,” Arthritis and Rheumatism 58, no. 7 (2008): 2065–2074. [DOI] [PubMed] [Google Scholar]
  • 19.Irwin RM, Gao T, Boys AJ, Ortved K, Cohen I, and Bonassar LJ, “Microscale Strain Mapping Demonstrates the Importance of Interface Slope in the Mechanics of Cartilage Repair,” Journal of Biomechanics 114 (2021): 110159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Waller KA, Zhang LX, Elsaid KA, Fleming BC, Warman ML, and Jay GD, “Role of Lubricin and Boundary Lubrication in the Prevention of Chondrocyte Apoptosis,” Proceedings of the National Academy of Sciences 110, no. 15 (2013): 5852–5857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Waller KA, Chin KE, Jay GD, et al. , “Intra-Articular Recombinant Human Proteoglycan 4 Mitigates Cartilage Damage After Destabilization of the Medial Meniscus in the Yucatan Minipig,” American Journal of Sports Medicine 45, no. 7 (2017): 1512–1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bartell LR, Fortier LA, Bonassar LJ, and Cohen I, “Measuring Microscale Strain Fields in Articular Cartilage During Rapid Impact Reveals Thresholds for Chondrocyte Death and a Protective Role for the Superficial Layer,” Journal of Biomechanics 48, no. 12 (2015): 3440–3446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bonnevie ED, Delco ML, Bartell LR, et al. , “Microscale Frictional Strains Determine Chondrocyte Fate in Loaded Cartilage,” Journal of Biomechanics 74 (2018): 72–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gleghorn JP and Bonassar LJ, “Lubrication Mode Analysis of Articular Cartilage Using Stribeck Surfaces,” Journal of Biomechanics 41, no. 9 (2008): 1910–1918. [DOI] [PubMed] [Google Scholar]
  • 25.Gleghorn JP, Jones ARC, Flannery CR, and Bonassar LJ, “Boundary Mode Lubrication of Articular Cartilage by Recombinant Human Lubricin,” Journal of Orthopaedic Research 27, no. 6 (2009): 771–777. [DOI] [PubMed] [Google Scholar]
  • 26.Flannery CR, Hughes CE, Schumacher BL, et al. , “Articular Cartilage Superficial Zone Protein (SZP) Is Homologous to Megakaryocyte Stimulating Factor Precursor and Is a Multifunctional Proteoglycan With Potential Growth-Promoting, Cytoprotective, and Lubricating Properties in Cartilage Metabolism,” Biochemical and Biophysical Research Communications 254, no. 3 (1999): 535–541. [DOI] [PubMed] [Google Scholar]
  • 27.Jay GD, “Characterization of a Bovine Synovial Fluid Lubricating Factor. I. Chemical, Surface Activity and Lubricating Properties,” Connective Tissue Research 28, no. 1–2 (1992): 71–88. [DOI] [PubMed] [Google Scholar]
  • 28.Greene GW, “Adaptive Mechanically Controlled Lubrication Mechanism Found in Articular Joints,” Biophysical Journal 100, no. 3 (2011): 607a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Schmidt TA, Gastelum NS, Nguyen QT, Schumacher BL, and Sah RL, “Boundary Lubrication of Articular Cartilage: Role of Synovial Fluid Constituents,” Arthritis and Rheumatism 56, no. 3 (2007): 882–891. [DOI] [PubMed] [Google Scholar]
  • 30.Balazs EA and Denlinger JL, “Viscosupplementation: A New Concept in the Treatment of Osteoarthritis,” Journal of Rheumatology Supplement 39 (1993): 3–9. [PubMed] [Google Scholar]
  • 31.Bellamy N, Campbell J, Robinson V, et al. , “Viscosupplementation for the Treatment of Osteoarthritis of the Knee,” Cochrane Database of Systematic Reviews 2006, no. 2 (2006): CD005321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shurer CR, Wang Y, Feeney E, et al. , “Stable Recombinant Production of Codon-Scrambled Lubricin and Mucin in Human Cells,” Biotechnology and Bioengineering 116, no. 6 (2019): 1292–1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Colville MJ, Huang L-T, Schmidt S, et al. 2024. Recombinant Manufacturing of Multispecies Biolubricants. BioRxiv :2024.05.05.592580. [Google Scholar]
  • 34.Waller KA, Chin KE, Jay GD, et al. , “Intra-articular Recombinant Human Proteoglycan 4 Mitigates Cartilage Damage After Destabilization of the Medial Meniscus in the Yucatan Minipig,” American Journal of Sports Medicine 45, no. 7 (2017): 1512–1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Prajapati M, Vishwanath K, Huang L, et al. , “Specific Degradation of the Mucin Domain of Lubricin in Synovial Fluid Impairs Cartilage Lubrication,” ACS Biomaterials Science and Engineering 10 (2024): 6915–6926, 10.1021/acsbiomaterials.4c00908. [DOI] [PubMed] [Google Scholar]
  • 36.Jay GD, Britt DE, and Cha CJ, “Lubricin Is a Product of Megakaryocyte Stimulating Factor Gene Expression by Human Synovial Fibroblasts,” Journal of Rheumatology 27, no. 3 (2000): 594–600. [PubMed] [Google Scholar]
  • 37.Schaefer DB, Wendt D, Moretti M, et al. , “Lubricin Reduces Cartilage–Cartilage Integration,” Biorheology 41, no. 3–4 (2004): 503–508. [PubMed] [Google Scholar]
  • 38.Englert C, McGowan KB, Klein TJ, Giurea A, Schumacher BL, and Sah RL, “Inhibition of Integrative Cartilage Repair by Proteoglycan 4 in Synovial Fluid,” Arthritis and Rheumatism 52, no. 4 (2005): 1091–1099. [DOI] [PubMed] [Google Scholar]
  • 39.Zhao C, Wei Z, Reisdorf RL, et al. , “The Effects of Biological Lubricating Molecules on Flexor Tendon Reconstruction in a Canine Allograft Model In Vivo,” Plastic and Reconstructive Surgery 133, no. 5 (2014): 628e–637e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Coughlin KM, Peura GD, Fleming BC, Hallock S, and Beynnon BD, “In Vivo Loads in the Medial Compartment of the Rabbit Knee,” Clinical Biomechanics 20, no. 9 (2005): 1007–1009. [DOI] [PubMed] [Google Scholar]
  • 41.Vishwanath K, Su J, Colville MJ, et al. , “Bioengineered Lubricin Alters the Lubrication Modes of Cartilage in a Dose-Dependent Manner,” Journal Orthopaedic Research 43, no. 3 (2024): jor.26009. [DOI] [PubMed] [Google Scholar]
  • 42.Menon NG, Tanguay AP, Zhou L, et al. , “A Structural and Functional Comparison Between Two Recombinant Human Lubricin Proteins: Recombinant Human Proteoglycan-4 (rhPRG4) vs ECF843,” Experimental Eye Research 235 (2023): 109643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Peterson L, Minas T, Brittberg M, Nilsson A, Sjögren-Jansson E, and Lindahl A, “Two- to 9-Year Outcome After Autologous Chondrocyte Transplantation of the Knee,” Clinical Orthopaedics and Related Research 374, no. 1976–2007 (2000): 212–234. [DOI] [PubMed] [Google Scholar]
  • 44.Brittberg M and Peterson L, “Introduction of an Articular Cartilage Classification,” ICRS Newsletter 1, no. 1 (1998): 5–8. [Google Scholar]
  • 45.Goebel L, Orth P, Müller A, et al. , “Experimental Scoring Systems for Macroscopic Articular Cartilage Repair Correlate With the MOCART Score Assessed by a High-Field Mri at 9.4 T – Comparative Evaluation of Five Macroscopic Scoring Systems in a Large Animal Cartilage Defect Model,” Osteoarthritis and Cartilage 20, no. 9 (2012): 1046–1055. [DOI] [PubMed] [Google Scholar]
  • 46.Bonnevie ED, Delco ML, Galesso D, Secchieri C, Fortier LA, and Bonassar LJ, “Sub-Critical Impact Inhibits the Lubricating Mechanisms of Articular Cartilage,” Journal of Biomechanics 53 (2017): 64–70. [DOI] [PubMed] [Google Scholar]
  • 47.Bonnevie ED, McCorry MC, and Bonassar LJ, “Mesenchymal Stem Cells Enhance Lubrication of Engineered Meniscus Through Lubricin Localization in Collagen Gels,” Biotribology 8 (2016): 26–32. [Google Scholar]
  • 48.Schindelin J, Arganda-Carreras I, Frise E, et al. , “Fiji: An Open-Source Platform for Biological-Image Analysis,” Nature Methods 9, no. 7 (2012): 676–682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ortved KF, Begum L, Mohammed HO, and Nixon AJ, “Implantation of rAAV5-IGF-I Transduced Autologous Chondrocytes Improves Cartilage Repair in Full-Thickness Defects in the Equine Model,” Molecular Therapy 23, no. 2 (2015): 363–373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Reesink HL, Watts AE, Mohammed HO, Jay GD, and Nixon AJ, “Lubricin/Proteoglycan 4 Increases in Both Experimental and Naturally Occurring Equine Osteoarthritis,” Osteoarthritis and Cartilage 25, no. 1 (2017): 128–137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ai M, Cui Y, Sy M-S, et al. , “Anti-Lubricin Monoclonal Antibodies Created Using Lubricin-Knockout Mice Immunodetect Lubricin in Several Species and in Patients With Healthy and Diseased Joints,” PLoS One 10, no. 2 (2015): e0116237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Soulhat J, Buschmann MD, and Shirazi-Adl A, “A Fibril-Network-Reinforced Biphasic Model of Cartilage in Unconfined Compression,” Journal of Biomechanical Engineering 121, no. 3 (1999): 340–347. [DOI] [PubMed] [Google Scholar]
  • 53.Mow VC, Kuei SC, Lai WM, and Armstrong CG, “Biphasic Creep and Stress Relaxation of Articular Cartilage in Compression? Theory and Experiments,” Journal of Biomechanical Engineering 102, no. 1 (1980): 73–84. [DOI] [PubMed] [Google Scholar]
  • 54.Li LP and Herzog W, “The Role of Viscoelasticity of Collagen Fibers in Articular Cartilage: Theory and Numerical Formulation,” Biorheology: The Official Journal of the International Society of Biorheology 41, no. 3–4 (2004): 181–194. [PubMed] [Google Scholar]
  • 55.Park S, Krishnan R, Nicoll SB, and Ateshian GA, “Cartilage Interstitial Fluid Load Support in Unconfined Compression,” Journal of Biomechanics 36, no. 12 (2003): 1785–1796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bonnevie ED, Galesso D, Secchieri C, and Bonassar LJ, “Frictional Characterization of Injectable Hyaluronic Acids Is More Predictive of Clinical Outcomes Than Traditional Rheological or Viscoelastic Characterization,” PLoS One 14, no. 5 (2019): e0216702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bonnevie ED, Galesso D, Secchieri C, Cohen I, and Bonassar LJ, “Elastoviscous Transitions of Articular Cartilage Reveal a Mechanism of Synergy Between Lubricin and Hyaluronic Acid,” PLoS One 10, no. 11 (2015): e0143415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Hill A, Waller KA, Cui Y, et al. , “Lubricin Restoration in a Mouse Model of Congenital Deficiency,” Arthritis and Rheumatology 67, no. 11 (2015): 3070–3081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Zhang D, Cheriyan T, Martin SD, Gomoll AH, Schmid TM, and Spector M, “Lubricin Distribution in the Torn Human Anterior Cruciate Ligament and Meniscus,” Journal of Orthopaedic Research 29, no. 12 (2011): 1916–1922. [DOI] [PubMed] [Google Scholar]
  • 60.Tarafder S, Ghataure J, Langford D, et al. , “Advanced Bioactive Glue Tethering Lubricin/PRG4 to Promote Integrated Healing of Avascular Meniscus Tears,” Bioactive Materials 28 (2023): 61–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Hybart R, Villancio-Wolter KS, and Ferris DP, “Metabolic Cost of Walking With Electromechanical Ankle Exoskeletons Under Proportional Myoelectric Control on a Treadmill and Outdoors,” PeerJ 11 (2023): e15775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, and Rodkey WG, “Outcomes of Microfracture for Traumatic Chondral Defects of the Knee: Average 11-Year Follow-up,” Arthroscopy: The Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 19, no. 5 (2003): 477–484. [DOI] [PubMed] [Google Scholar]
  • 63.Mithoefer K, Williams RJ, Warren RF, et al. , “The Microfracture Technique for the Treatment of Articular Cartilage Lesions in the Knee: A Prospective Cohort Study,” Journal of Bone and Joint Surgery-American Volume 87, no. 9 (2005): 1911–1920. [DOI] [PubMed] [Google Scholar]
  • 64.Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, and Peterson L, “Treatment of Deep Cartilage Defects in the Knee With Autologous Chondrocyte Transplantation,” New England Journal of Medicine 331, no. 14 (1994): 889–895. [DOI] [PubMed] [Google Scholar]
  • 65.Bartlett W, Skinner JA, Gooding CR, et al. , “Autologous Chondrocyte Implantation Versus Matrix-Induced Autologous Chondrocyte Implantation for Osteochondral Defects of the Knee: A Prospective, Randomised Study,” Journal of Bone and Joint Surgery. British Volume 87, no. 5 (2005): 640–645. [DOI] [PubMed] [Google Scholar]
  • 66.Minas T, “Autologous Chondrocyte Implantation in the Arthritic Knee,” Orthopedics 26, no. 9 (2003): 945–947. [DOI] [PubMed] [Google Scholar]
  • 67.Petrera M, De Croos JN, Iu J, Hurtig M, Kandel RA, and Theodoropoulos JS, “Supplementation With Platelet-Rich Plasma Improves the In Vitro Formation of Tissue-Engineered Cartilage With Enhanced Mechanical Properties,” Arthroscopy: The Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 29, no. 10 (2013): 1685–1692. [DOI] [PubMed] [Google Scholar]
  • 68.Middendorf JM, Griffin DJ, Shortkroff S, et al. , “Mechanical Properties and Structure-Function Relationships of Human Chondrocyte-Seeded Cartilage Constructs After In Vitro Culture,” Journal of Orthopaedic Research 35, no. 10 (2017): 2298–2306. [DOI] [PubMed] [Google Scholar]
  • 69.Evenbratt H, Andreasson L, Bicknell V, Brittberg M, Mobini R, and Simonsson S, “Insights Into the Present and Future of Cartilage Regeneration and Joint Repair,” Cell Regeneration 11, no. 1 (2022): 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.García-Carvajal ZY, Garciadiego-Cázares D, Parra-Cid C, et al. 2013. “Cartilage Tissue Engineering: The Role of Extracellular Matrix (ECM) and Novel Strategies,” in Regenerative Medicine and Tissue Engineering. IntechOpen, https://www.intechopen.com/chapters/44622. [Google Scholar]
  • 71.Masson AO and Krawetz RJ, “Understanding Cartilage Protection in OA and Injury: A Spectrum of Possibilities,” BMC Musculoskeletal Disorders 21, no. 1 (2020): 432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Ihnatouski M, Pauk J, Karev B, and Karev D, “Nanomechanical Properties of Articular Cartilage Due to the PRP Injection in Experimental Osteoarthritis in Rabbits,” Molecules 25, no. 16 (2020): 3734, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463443/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Watkins AR and Reesink HL, “Lubricin in Experimental and Naturally Occurring Osteoarthritis: A Systematic Review,” Osteoarthritis and Cartilage 28, no. 10 (2020): 1303–1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Jay GD, Elsaid KA, Kelly KA, et al. , “Prevention of Cartilage Degeneration and Gait Asymmetry by Lubricin Tribosupplementation in the Rat Following Anterior Cruciate Ligament Transection,” Arthritis and Rheumatism 64, no. 4 (2012): 1162–1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Jay GD, Torres JR, Rhee DK, et al. , “Association Between Friction and Wear in Diarthrodial Joints Lacking Lubricin,” Arthritis and Rheumatism 56, no. 11 (2007): 3662–3669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Coles JM, Zhang L, Blum JJ, et al. , “Loss of Cartilage Structure, Stiffness, and Frictional Properties in Mice Lacking PRG4,” Arthritis and Rheumatism 62, no. 6 (2010): 1666–1674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Raleigh AR, Cravotta MJ, Garcia JJ, et al. , “Decreased Synovial Fluid Proteoglycan-4 Concentration in ACL-Transected Knee Joints Is Due to a Dynamic Imbalance in Biosynthesis, Clearance, and Effusion,” Osteoarthritis and Cartilage 26 (2018): S397. [Google Scholar]
  • 78.Elsaid KA, Jay GD, Warman ML, Rhee DK, and Chichester CO, “Association of Articular Cartilage Degradation and Loss of Boundary-Lubricating Ability of Synovial Fluid Following Injury and Inflammatory Arthritis,” Arthritis and Rheumatism 52, no. 6 (2005): 1746–1755. [DOI] [PubMed] [Google Scholar]
  • 79.Ateshian GA, “The Role of Interstitial Fluid Pressurization in Articular Cartilage Lubrication,” Journal of Biomechanics 42, no. 9 (2009): 1163–1176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Ateshian GA and Wang H, “A Theoretical Solution for the Frictionless Rolling Contact of Cylindrical Biphasic Articular Cartilage Layers,” Journal of Biomechanics 28, no. 11 (1995): 1341–1355. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Files

RESOURCES